Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer ; volume:14 ; number:1 ; day:6 ; month:1 ; year:2012 ; pages:1-11 ; date:2.2012
Breast cancer research ; 14, Heft 1 (6.1.2012), 1-11, 2.2012
- Creator
-
Aleskandarany, Mohammed A.
- Contributor
-
Green, Andrew R.
Benhasouna, Ahmed A.
Barros, Fabricio F.
Neal, Keith
Reis-Filho, Jorge S.
Ellis, Ian O.
Rakha, Emad A.
SpringerLink (Online service)
- DOI
-
10.1186/bcr3084
- URN
-
urn:nbn:de:1111-2016032414258
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aleskandarany, Mohammed A.
- Green, Andrew R.
- Benhasouna, Ahmed A.
- Barros, Fabricio F.
- Neal, Keith
- Reis-Filho, Jorge S.
- Ellis, Ian O.
- Rakha, Emad A.
- SpringerLink (Online service)
Other Objects (12)
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer
Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte
PYK2 promotes HER2-positive breast cancer invasion
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Nanotechnology approaches to addressing HER2-positive breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer
Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte
PYK2 promotes HER2-positive breast cancer invasion
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Nanotechnology approaches to addressing HER2-positive breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer
Das HER2-positive metastasierte Mammakarzinom – aktuelle Behandlungskonzepte
PYK2 promotes HER2-positive breast cancer invasion
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Nanotechnology approaches to addressing HER2-positive breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients